ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic
Accelerating COVID-19 Treatment Interventions and Vaccines (ACTIV) was initiated by the US government to rapidly develop and test vaccines and therapeutics against COVID-19 in 2020. The ACTIV Therapeutics-Clinical Working Group selected ACTIV trial teams and clinical networks to expeditiously develo...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cambridge University Press
2024-01-01
|
| Edice: | Journal of Clinical and Translational Science |
| Témata: | |
| On-line přístup: | https://www.cambridge.org/core/product/identifier/S2059866124000013/type/journal_article |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
